Projects

This project serves as a container for all COVID-19 related assets, developed at the University of Leipzig and its partners.

Historic retinal images of subjects with diabetes are scanned and analysed using modern technology. The accuracy of the methods and the usefulness of the findings in the long-term are in the focus. University of Oulu, Department of Ophthalmology/PEDEGO Research Unit 194/2006

FAIR4Health is a Horizon 2020 project which aims to FAIRify medical datasets.

The aim of oBIG is to establish modern genome bioinformatics in Armenia to investigate genesis and progression of complex diseases. Therefore we will extend the collaboration between the Interdisciplinary Center for Bioinformatics (IZBI) of Leipzig University and the Institute of Molecular Biology (IMB) in Yerevan, Armenia, to accomplish three main aspects of the project:Firstly, current research topics in systems biology of cancer, lung diseases and infections will be addressed by a joint team ...

The vision of Immune Safety Avatar (imSAVAR) is to develop a platform for integrated nonclinical assessments of immunomodulatory therapy safety and efficacy.The imSAVAR is an Innovative Medicines Initiative funded project that aims to develop a standard for integrated nonclinical safety overviews for immune-modulatory investigational new drugs (IND) and clinical trial applications (CTA).Our imSAVAR platform will improve the prediction of the transferability of safety and efficacy of immunomodulators ...

Analysis of the humoral response against HLA alloantigens is performed using museal methods. With the use of AI we aim to predict deleterious antibody production avoiding allograft deterioration and graft loss.

The aim of this project is to validate and improve an in vitro test system developed in a previous project for the prediction of hepatotoxicity induced by chemical substances and drugs. For this purpose, the test system will be supplemented with immunological cells in order to be able to detect idiosyncratic reactions. In the subproject of the working group of Prof. Daniel Seehofer and Dr. Georg Damm, primary liver cells will be provided and the in vitro model will be improved by Kupffer cells.